The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Breast Cancer Diagnostic and Drug Technologies Market Research Report 2025
Synopsis
Breast cancer is a malignant tumor that occurs in the epithelial tissue of the breast gland.Breast Cancer Diagnostic and Drug Technologies include mammography, biopsy and so on.
The global Breast Cancer Diagnostic and Drug Technologies market was valued at US$ 16050 million in 2023 and is anticipated to reach US$ 19060 million by 2030, witnessing a CAGR of 2.0% during the forecast period 2024-2030.
North American market for Breast Cancer Diagnostic and Drug Technologies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Breast Cancer Diagnostic and Drug Technologies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Breast Cancer Diagnostic and Drug Technologies in Ductal Carcinoma of Breast is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Breast Cancer Diagnostic and Drug Technologies include Abbott, Roche, BioMerieux, Becton Dickinson, GE Healthcare, Hologic, Philips, PerkinElmer and Quest Diagnostics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Breast Cancer Diagnostic and Drug Technologies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Breast Cancer Diagnostic and Drug Technologies.
Report Scope
The Breast Cancer Diagnostic and Drug Technologies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Breast Cancer Diagnostic and Drug Technologies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Breast Cancer Diagnostic and Drug Technologies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Roche
BioMerieux
Becton Dickinson
GE Healthcare
Hologic
Philips
PerkinElmer
Quest Diagnostics
Segment by Type
Mammography
Biopsy
Other
Segment by Application
Ductal Carcinoma of Breast
Invasive Ductal Carcinoma
Lobular Carcinoma
Triple Negative Breast Cancer
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Breast Cancer Diagnostic and Drug Technologies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Breast cancer is a malignant tumor that occurs in the epithelial tissue of the breast gland.Breast Cancer Diagnostic and Drug Technologies include mammography, biopsy and so on.
The global Breast Cancer Diagnostic and Drug Technologies market was valued at US$ 16050 million in 2023 and is anticipated to reach US$ 19060 million by 2030, witnessing a CAGR of 2.0% during the forecast period 2024-2030.
North American market for Breast Cancer Diagnostic and Drug Technologies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Breast Cancer Diagnostic and Drug Technologies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Breast Cancer Diagnostic and Drug Technologies in Ductal Carcinoma of Breast is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Breast Cancer Diagnostic and Drug Technologies include Abbott, Roche, BioMerieux, Becton Dickinson, GE Healthcare, Hologic, Philips, PerkinElmer and Quest Diagnostics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Breast Cancer Diagnostic and Drug Technologies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Breast Cancer Diagnostic and Drug Technologies.
Report Scope
The Breast Cancer Diagnostic and Drug Technologies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Breast Cancer Diagnostic and Drug Technologies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Breast Cancer Diagnostic and Drug Technologies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Roche
BioMerieux
Becton Dickinson
GE Healthcare
Hologic
Philips
PerkinElmer
Quest Diagnostics
Segment by Type
Mammography
Biopsy
Other
Segment by Application
Ductal Carcinoma of Breast
Invasive Ductal Carcinoma
Lobular Carcinoma
Triple Negative Breast Cancer
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Breast Cancer Diagnostic and Drug Technologies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Breast Cancer Diagnostic and Drug Technologies Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Mammography
1.2.3 Biopsy
1.2.4 Other
1.3 Market by Application
1.3.1 Global Breast Cancer Diagnostic and Drug Technologies Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Ductal Carcinoma of Breast
1.3.3 Invasive Ductal Carcinoma
1.3.4 Lobular Carcinoma
1.3.5 Triple Negative Breast Cancer
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Breast Cancer Diagnostic and Drug Technologies Market Perspective (2019-2030)
2.2 Breast Cancer Diagnostic and Drug Technologies Growth Trends by Region
2.2.1 Global Breast Cancer Diagnostic and Drug Technologies Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Breast Cancer Diagnostic and Drug Technologies Historic Market Size by Region (2019-2024)
2.2.3 Breast Cancer Diagnostic and Drug Technologies Forecasted Market Size by Region (2025-2030)
2.3 Breast Cancer Diagnostic and Drug Technologies Market Dynamics
2.3.1 Breast Cancer Diagnostic and Drug Technologies Industry Trends
2.3.2 Breast Cancer Diagnostic and Drug Technologies Market Drivers
2.3.3 Breast Cancer Diagnostic and Drug Technologies Market Challenges
2.3.4 Breast Cancer Diagnostic and Drug Technologies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Breast Cancer Diagnostic and Drug Technologies Players by Revenue
3.1.1 Global Top Breast Cancer Diagnostic and Drug Technologies Players by Revenue (2019-2024)
3.1.2 Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Players (2019-2024)
3.2 Global Breast Cancer Diagnostic and Drug Technologies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Breast Cancer Diagnostic and Drug Technologies Revenue
3.4 Global Breast Cancer Diagnostic and Drug Technologies Market Concentration Ratio
3.4.1 Global Breast Cancer Diagnostic and Drug Technologies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Breast Cancer Diagnostic and Drug Technologies Revenue in 2023
3.5 Breast Cancer Diagnostic and Drug Technologies Key Players Head office and Area Served
3.6 Key Players Breast Cancer Diagnostic and Drug Technologies Product Solution and Service
3.7 Date of Enter into Breast Cancer Diagnostic and Drug Technologies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Breast Cancer Diagnostic and Drug Technologies Breakdown Data by Type
4.1 Global Breast Cancer Diagnostic and Drug Technologies Historic Market Size by Type (2019-2024)
4.2 Global Breast Cancer Diagnostic and Drug Technologies Forecasted Market Size by Type (2025-2030)
5 Breast Cancer Diagnostic and Drug Technologies Breakdown Data by Application
5.1 Global Breast Cancer Diagnostic and Drug Technologies Historic Market Size by Application (2019-2024)
5.2 Global Breast Cancer Diagnostic and Drug Technologies Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Breast Cancer Diagnostic and Drug Technologies Market Size (2019-2030)
6.2 North America Breast Cancer Diagnostic and Drug Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2019-2024)
6.4 North America Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Breast Cancer Diagnostic and Drug Technologies Market Size (2019-2030)
7.2 Europe Breast Cancer Diagnostic and Drug Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2019-2024)
7.4 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size (2019-2030)
8.2 Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Region (2019-2024)
8.4 Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Breast Cancer Diagnostic and Drug Technologies Market Size (2019-2030)
9.2 Latin America Breast Cancer Diagnostic and Drug Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2019-2024)
9.4 Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size (2019-2030)
10.2 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2019-2024)
10.4 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Breast Cancer Diagnostic and Drug Technologies Introduction
11.1.4 Abbott Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2019-2024)
11.1.5 Abbott Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Breast Cancer Diagnostic and Drug Technologies Introduction
11.2.4 Roche Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2019-2024)
11.2.5 Roche Recent Development
11.3 BioMerieux
11.3.1 BioMerieux Company Detail
11.3.2 BioMerieux Business Overview
11.3.3 BioMerieux Breast Cancer Diagnostic and Drug Technologies Introduction
11.3.4 BioMerieux Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2019-2024)
11.3.5 BioMerieux Recent Development
11.4 Becton Dickinson
11.4.1 Becton Dickinson Company Detail
11.4.2 Becton Dickinson Business Overview
11.4.3 Becton Dickinson Breast Cancer Diagnostic and Drug Technologies Introduction
11.4.4 Becton Dickinson Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2019-2024)
11.4.5 Becton Dickinson Recent Development
11.5 GE Healthcare
11.5.1 GE Healthcare Company Detail
11.5.2 GE Healthcare Business Overview
11.5.3 GE Healthcare Breast Cancer Diagnostic and Drug Technologies Introduction
11.5.4 GE Healthcare Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2019-2024)
11.5.5 GE Healthcare Recent Development
11.6 Hologic
11.6.1 Hologic Company Detail
11.6.2 Hologic Business Overview
11.6.3 Hologic Breast Cancer Diagnostic and Drug Technologies Introduction
11.6.4 Hologic Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2019-2024)
11.6.5 Hologic Recent Development
11.7 Philips
11.7.1 Philips Company Detail
11.7.2 Philips Business Overview
11.7.3 Philips Breast Cancer Diagnostic and Drug Technologies Introduction
11.7.4 Philips Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2019-2024)
11.7.5 Philips Recent Development
11.8 PerkinElmer
11.8.1 PerkinElmer Company Detail
11.8.2 PerkinElmer Business Overview
11.8.3 PerkinElmer Breast Cancer Diagnostic and Drug Technologies Introduction
11.8.4 PerkinElmer Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2019-2024)
11.8.5 PerkinElmer Recent Development
11.9 Quest Diagnostics
11.9.1 Quest Diagnostics Company Detail
11.9.2 Quest Diagnostics Business Overview
11.9.3 Quest Diagnostics Breast Cancer Diagnostic and Drug Technologies Introduction
11.9.4 Quest Diagnostics Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2019-2024)
11.9.5 Quest Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
